RxDoctor Payments Data

Bill Sbiliris, MD

Psychiatry · Glendale, AZNPI 1710017355

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Alkermes, Inc. accounts for 79.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $4,580 and has fallen 89.5% since, to $481 in 2025. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,806in general payments, 2019–2025

Across 84 payments — averaging $81.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$5K
  • Janssen Scientific Affairs, LLC$367
  • E.r. Squibb & Sons, L.L.C.$300
  • Johnson & Johnson$222
  • Indivior Inc.$166
  • AbbVie$147
  • plus $218 from 3 others

What the payments were for

  • Speaking & faculty fees$3,74055%
  • Food & beverage$2,97444%
  • Education$921%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,806 in reported general payments places this provider in the 90th percentile of 573 psychiatry providers in Arizona.

See all psychiatry providers in Arizona

Medicare billing

Part B allowed, 2024
$18,609
Medicare patients
35
Services billed
228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olanzapine OdtOlanzapine13$800
Clozapine11$316
Hydroxyzine Pamoate41$264
Gabapentin22$155
Quetiapine Fumarate17$153
Trazodone Hcl19$90
Risperidone13$85

Paid to pharmacies, not to this prescriber.

Other psychiatry in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →